GOOG
44
-2
KO
59
4
SYY
44
-4
TEL
61
-13
GME
86
5
FE
64
-2
MCK
73
2
STX
69
-2
ADI
63
2
AMGN
23
-3
FSLR
44
4
WU
30
-2
RIG
32
3
PH
77
2
PCAR
40
-2
K
54
-5
EXPE
72
-9
EBAY
53
-5
PBI
53
-3
CMS
67
9
GOOG
44
-2
KO
59
4
SYY
44
-4
TEL
61
-13
GME
86
5
FE
64
-2
MCK
73
2
STX
69
-2
ADI
63
2
AMGN
23
-3
FSLR
44
4
WU
30
-2
RIG
32
3
PH
77
2
PCAR
40
-2
K
54
-5
EXPE
72
-9
EBAY
53
-5
PBI
53
-3
CMS
67
9
Financhill
Back

Theriva Biologics Stock Price Chart

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
11

TOVX
Theriva Biologics

Last Price:
$0.52
Seasonality Move:
-6.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight selling pressure.

Theriva Biologics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Sell
20-day SMA: 1.27 Sell
50-day SMA: 1.23 Sell
200-day SMA: 2.1 Sell
8-day EMA: 0.99 Sell
20-day EMA: 1.16 Sell
50-day EMA: 1.25 Sell
200-day EMA: 2.86 Sell

Theriva Biologics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 21.04 Sell
Chaikin Money Flow: -514867 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.98 - 1.48) Sell
Bollinger Bands (100): (1.13 - 1.55) Sell

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Theriva Biologics Stock

Is Theriva Biologics Stock a Buy?

  • Theriva Biologics share price is 0.53 while TOVX 8-day simple moving average is 1.11, which is a Sell signal.
  • The stock price of TOVX is 0.53 while Theriva Biologics 20-day SMA is 1.27, which makes it a Sell.
  • Theriva Biologics 50-day simple moving average is 1.23 while TOVX share price is 0.53, making it a Sell technically.
  • TOVX stock price is 0.53 and Theriva Biologics 200-day simple moving average is 2.10, creating a Sell signal.

TOVX Technical Analysis vs Fundamental Analysis

Sell
11
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $0.53. The Score for TOVX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.

Theriva Biologics Stock Info

Market Cap:
1.5M
Price in USD:
0.53
Share Volume:
1.4M

Theriva Biologics 52-Week Range

52-Week High:
10.75
52-Week Low:
0.47
Sell
11
Theriva Biologics (TOVX) is a Sell

Theriva Biologics Share Price Forecast

Is Theriva Biologics Stock a Buy?

  • Theriva Biologics share price is 0.53 while TOVX 8-day exponential moving average is 0.99, which is a Sell signal.
  • The stock price of TOVX is 0.53 while Theriva Biologics 20-day EMA is 1.16, which makes it a Sell.
  • Theriva Biologics 50-day exponential moving average is 1.25 while TOVX share price is 0.53, making it a Sell technically.
  • TOVX stock price is 0.53 and Theriva Biologics 200-day simple moving average is 2.86, creating a Sell signal.

Fundamental Analysis of Theriva Biologics

Is Theriva Biologics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Theriva Biologics

Should I short Theriva Biologics stock?

* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.